PlainPharmaWatch

CMS Open Payments · Tool

Mizuho America, Inc. vs Agfa HealthCare Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Agfa HealthCare Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,487, versus 2,287 for the other company. Its single largest recorded recipient represents 39.0% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Mizuho America, Inc.
HHI 2,287 · top recipient 31.7%
Ranked #699 of 1,838 companies by HHI
Agfa HealthCare Corporation
HHI 2,487 · top recipient 39.0%
Ranked #653 of 1,838 companies by HHI

Payment Overview

Total Payments
$403.0K
% of Industry
0.0%
Transactions
57
Avg per Transaction
$7.1K
Recipients
57
Avg per Recipient
$7.1K
Payment Types
5
Top Payment Type
Royalty or License
Total Payments
$400.9K
% of Industry
0.0%
Transactions
49
Avg per Transaction
$8.2K
Recipients
49
Avg per Recipient
$8.2K
Payment Types
3
Top Payment Type
Gift

Highlighted values indicate the higher figure for each metric.

Total payments compared

Mizuho America, Inc. vs Agfa HealthCare Corporation - total reported payments in CMS Open Payments PY2024

Mizuho America, Inc.$403.0KAgfa HealthCare Corporation$400.9K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Mizuho America, Inc.

Royalty or License $369.4K

91.6%

Charitable Contribution $26.0K

6.5%

Compensation for Services Other Than Consulting $6.0K

1.5%

Food and Beverage $1.5K

0.4%

Space Rental or Facility Fees $125.11

0.0%

Agfa HealthCare Corporation

Gift $295.7K

73.8%

Charitable Contribution $103.3K

25.8%

Food and Beverage $1.9K

0.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Mizuho America, Inc.

  1. 1

    James J Evans

    $127,671.04 · 4 txns

  2. 2

    Michael T Lawton

    $116,010.22 · 6 txns

  3. 3

    Daniel F Kelly

    $79,766.94 · 4 txns

  4. 4

    Harborview Medical Center

    $20,000.00 · 1 txns

  5. 5

    Julian E Bailes JR.

    $14,845.60 · 8 txns

Agfa HealthCare Corporation

  1. 1

    University Health System

    $156,288.50 · 5 txns

  2. 2

    Ronald Reagan Ucla

    $101,442.00 · 2 txns

  3. 3

    Adventhealth Orlando

    $65,000.00 · 1 txns

  4. 4

    Umass Memorial Medical Center

    $20,405.00 · 2 txns

  5. 5

    Santa Clara Valley Medical Center

    $16,032.50 · 3 txns

Summary Comparison

Metric Mizuho America, Inc. Agfa HealthCare Corporation
Total Payments $403.0K $400.9K
% of Industry Total 0.0% 0.0%
Transaction Count 57 49
Avg per Transaction $7.1K $8.2K
Recipient Count 57 49
Avg per Recipient $7.1K $8.2K
Payment Type Count 5 3
Top Payment Type Royalty or License Gift

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.